Organization
Odette Cancer Centre
17 abstracts
Abstract
Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.Org: O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham School of Medicine, Clinical Trial Development Division, Roswell Park Comprehensive Cancer Center, Stephenson Cancer Center/University of Oklahoma Health Sciences Center and Sarah Cannon Research Institute, University of Oklahoma Health Sciences Center,
Abstract
Second primary breast cancer in young breast cancer survivors.Org: Harvard School of Public Health, Beth Israel Deaconess Medical Center and Harvard Medical School, Stanford Comprehensive Cancer Institute, Odette Cancer Centre, Beth Israel Deaconess Medical Center,
Abstract
The impact of admitting ward on resource utilization and outcomes among hospitalized cancer survivors.Org: Princess Margaret Cancer Centre, University of Toronto, Division of General Internal Medicine, St Michael's Hospital, Unity Health - St Michael's Hospital,
Abstract
Association of socioeconomic status with aggressive end-of-life care in patients with cancer before and during the COVID-19 pandemic.Org: University Health Network (UHN), University of Toronto, Queen's University Belfast, Princess Margaret Cancer Centre, Department of Biostatistics & Data Science,
Abstract
Neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer (NSCLC): A systematic review and extracted individual patient data meta-analysis.Org: Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto,
Abstract
Comparing the characteristics and outcomes of hospitalizations between cancer and non-cancer survivors.Org: University Health Network, Princess Margaret Cancer Centre, Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, Los Angeles, CA, St Michael's Hospital, University of Toronto,
Abstract
Fertility among young breast cancer survivors attempting pregnancy: A prospective, multicentre cohort study.Org: Dana-Farber Cancer Institute, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, Mayo Clinic, Massachusetts General Hospital, Stanford Comprehensive Cancer Institute,
Abstract
Impact of geography on receipt of medical oncology consultation and neoadjuvant chemotherapy for triple negative and HER2 positive breast cancer.Org: University of Toronto, Odette Cancer Centre, Sunnybrook Health Sciences Centre, ICES, Sunnybrook Odette Cancer Centre,
Abstract
Exactis-03: A phase I trial of the combination of olaparib and navitoclax in women with high grade serous ovarian cancer and triple negative breast cancer.Org: Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Montreal, Centre De Recherche Du Centre Hospitalier De L'université De Montréal (CRCHUM), Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,
Abstract
Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.Org: Odette Cancer Centre, Sunnybrook Health Sciences Centre, Duke University Medical Center, NRG Oncology, University of Iowa Hospitals and Clinics,
Abstract
Testosterone recovery following androgen suppression and prostate radiotherapy (TRANSPORT): Updated individual patient data meta-analyses from the MARCAP consortium.Org: Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, University of California Los Angeles, Alfred Health Radiation Oncology,
Abstract
A randomized phase II study comparing single-agent olaparib, single-agent cediranib, and the combinations of cediranib/olaparib, olaparib/durvalumab (MEDI4736), cediranib/durvalumab (MEDI4736), and olaparib/AZD5363 (capivasertib) in women with recurrent, persistent, or metastatic endometrial cancer.Org: Cedars-Sinai Medical Center, University of Iowa Hospitals and Clinics, NRG Oncology, University of Texas MD Anderson Cancer Center, Stephenson Cancer Center/University of Oklahoma Health Sciences Center and Sarah Cannon Research Institute,
Abstract
Associations between sarcopenia and clinical outcomes in men with metastatic castrate-resistant prostate cancer.Org: University Health Network, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Princess Margaret Cancer Centre,
Abstract
Understanding treatment toxicity patterns through remote symptom monitoring and examining the effect of frailty in older men with metastatic prostate cancer.Org: Princess Margaret Cancer Centre, University Health Network, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Odette Cancer Centre, Sunnybrook Health Sciences Centre,
Abstract
Feasibility of daily physical activity monitoring and associations with treatment toxicity in older adults with metastatic prostate cancer.Org: University Health Network, Princess Margaret Cancer Centre, National Institute of Medical Sciences and Nutrition Salvador Zubirán, University of Toronto, Odette Cancer Centre,
Abstract
Reflex MammaPrint testing on breast core biopsies: A single center experience.Org: University of Toronto, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Sunnybrook Health Sciences Center,
Abstract
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: A cost consequence analysis using linked administrative data.Org: Princess Margaret Cancer Centre, Institute for Clinical Evaluative Sciences, University Health Network, Sunnybrook Health Sciences Centre, Odette Cancer Centre,